Investing.com - J&J reported on Tuesday fourth quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
J&J announced earnings per share of $2.13 on revenue of $24.8B. Analysts polled by Investing.com anticipated EPS of $2.12 on revenue of $25.28B.
J&J shares are down 2% from the beginning of the year and are trading at $162.97 , down-from-52-week-high.They are outperforming the S&P 500 which is down 7.47% from the start of the year.
J&J follows other major Healthcare sector earnings this month
J&J's report follows an earnings beat by UnitedHealth on January 19, who reported EPS of $4.48 on revenue of $73.74B, compared to forecasts EPS of $4.3 on revenue of $72.98B.
Intuitive Surgical had beat expectations on Thursday with fourth quarter EPS of $1.3 on revenue of $1.55B, compared to forecast for EPS of $1.28 on revenue of $1.52B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar